6 studies found for:    10561265 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Pilot Study of the Administration of Young Tumor Infiltrating Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotrheraphy Regimen in Metastatic Melanoma
Conditions: Metastatic Melanoma;   Skin Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Young TIL
2 Recruiting A Phase II Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Comparing Two Different Chemotherapy Preparative Regimens
Condition: Metastatic Melanoma
Interventions: Drug: Aldesleukin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: Young Tumor Infiltrating Lymphocytes (young TIL)
3 Recruiting Dendritic Cells (White Blood Cells) Vaccination for Advanced Melanoma
Condition: Melanoma
Interventions: Drug: cyclophosphamide;   Biological: Mature dendritic cell vaccine
4 Suspended Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes
Conditions: Skin Cancer;   Metastatic Melanoma
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Other: Gene Transfer
5 Completed
Has Results
Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma
Conditions: Metastatic Melanoma;   Skin Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Aldesleukin;   Biological: Tumor Infiltrating Lymphocytes
6 Recruiting Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
Conditions: Metastatic Melanoma;   Skin Cancer
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Tumor Infiltrating Lymphocytes;   Drug: IL-15

Indicates status has not been verified in more than two years